The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 15, 2022
Filed:
Oct. 16, 2019
Abbvie Inc., North Chicago, IL (US);
Nancy E. Sever, Northbrook, IL (US);
Ulrich Westedt, Schriesheim, DE;
Ute Lander, Dannenfels, DE;
Katrin Schneider, Mannheim, DE;
Benedikt Steitz, Kallstadt, DE;
Thomas Mueller, Ludwigshafen, DE;
Regina Reul, Mannheim, DE;
Constanze Obermiller, Heidelberg, DE;
Adivaraha Jayasankar, Naperville, IL (US);
Michael Simon, Landau, DE;
Yi Gao, Vernon Hills, IL (US);
Harald Hach, Oberotterbach, DE;
Samuel Kyeremateng, Mannheim, DE;
Katharina Asmus, Neustadt a.d.W., DE;
Ping Tong, Potomoc, MD (US);
Donghua Zhu, Vernon Hills, IL (US);
Marius Naris, Downers Grove, IL (US);
Colleen Garrett, Chicago, IL (US);
AbbVie Inc., North Chicago, IL (US);
Abstract
The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first layer which comprises 100 mg Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second layer which comprises 40 mg Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.